The effects of ICG-001 on PANC1 cells and comparison to gene expression patterns in TCF7L2 knockdown cells suggests that ICG-001 inhibits proliferation of pancreatic cancer cells via a mechanism different than the WNT pathway. This evidence concerns the gene TCF7L2 and familial pancreatic carcinoma.